Technological advancements are rapidly redefining the scope and complexity of the IVD Contract Manufacturing Market, forcing CDMOs to invest heavily in specialized production capabilities for two major trends: the shift to decentralized Point-of-Care (PoC) testing and the expansion of Molecular Diagnostics (MDx). Furthermore, the adoption of Industry 4.0 principles (automation, smart factories,...
Romaian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Tiếng Việt